1. In epididymal adipose tissue synthesizing fatty acids from fructose in vitro, addition of insulin led to a moderate increase in fructose uptake, to a considerable increase in the flow of fructose carbon atoms to fatty acid, to a decrease in the steady-state concentration of lactate and pyruvate in the medium, and to net uptake of lactate and pyruvate from the medium. It is concluded that insulin accelerates a step in the span pyruvate--fatty acid. 2. Mitochondria prepared from fat-cells exposed to insulin put out more citrate than non-insulin-treated controls under conditions where the oxaloacetate moiety of citrate was formed from pyruvate by pyruvate carboxylase and under conditions where it was formed from malate. This suggested that insulin treatment of fat-cells led to persistent activation of pyruvate dehydrogenase. 3. Insulin treatment of epididymal fatpads in vitro increased the activity of pyruvate dehydrogenase measured in extracts of the tissue even in the absence of added substrate; the activities of pyruvate carboxylase, citrate synthase, glutamate dehydrogenase, acetyl-CoA carboxylase, NADP-malate dehydrogenase and NAD-malate dehydrogenase were not changed by insulin. 4. The effect of insulin on pyruvate dehydrogenase activity was inhibited by adrenaline, adrenocorticotrophic hormone and dibutyryl cyclic AMP (6-N,2'-O-dibutyryladenosine 3':5'-cyclic monophosphate). The effect of insulin was not reproduced by prostaglandin E1, which like insulin may lower the tissue concentration of cyclic AMP (adenosine 3':5'-cycic monophosphate) and inhibit lipolysis. 5. Adipose tissue pyruvate dehydrogenase in extracts of mitochondria is almost totally inactivated by incubation with ATP and can then be reactivated by incubation with lOmM-Mg2+. In this respect its properties are similar to that of pyruvate dehydrogenase from heart and kidney where evidence has been given that inactivation and activation are catalysed by an ATP-dependent kinase and a Mg2+-dependent phosphatase. Evidence is given that insulin may act by increasing the proportion of active (dephosphorylated) pyruvate dehydrogenase. 6. Cyclic AMP could not be shown to influence the activity of pyruvate dehydrogenase in mitochondria under various conditions of incubation. 7. These results are discussed in relation to the control of fatty acid synthesis in adipose tissue and the role of cyclic AMP in mediating the effects of insulin on pyruvate dehydrogenase.
The increase in fatty acid synthesis from glucose induced by insulin in rat epididymal adipose tissue is often in excess of 500%, whereas the associated increase in pyrtvate output is rarely greater than 200% (Denton, Halperin & Randle, 1968; Saggerson & Greenbaum, 1970a; Halperin & Robinson, 1970) . This preferential incorporation of pyruvate carbon atoms into fatty acids compared with its release from fat-pads in the presence of insulin led to the suggestion that insulin might specifically activate the conversion of pyruvate carbon atoms into fatty acid in addition to its well-established effect on glucose uptake . Adrenaline, on the other hand, may antagonize an action of insulin on the conversion of pyruvate carbon atoms into fatty acid because it increases the output of lactate and pyruvate from glucose and either inhibits or leaves unchanged the rate of incorporation of glucose carbon atoms into fatty acid Saggerson & Greenbaum, 1970a) .
In this paper we report effects of insulin on fructose metabolism in rat epididymal fat-pads which add further support for an effect of insulin on the conversion of pyruvate into fatty acid. Evidence is presented from studies on isolated fat-cell mitochondria and on enzyme activities measured in extracts of whole tissue and mitochondrial fractions which indicate that these effects of insulin and adrenaline are achieved at least in part by activation or inhibition respectively of pyruvate dehydrogenase (EC 1.2.4.1). Further analysis of the effect of insulin on the activity of pyruvate dehydrogenase indicates that it most probably operates via the phosphorylation-dephosphorylation cycle previously shown to influence the activity of the enzyme complex from heart, liver, kidney and brain (Linn, Pettit & Reed, 1969; Wieland & Siess, 1970; Siess, Wittman & Wieland, 1971) .
The activation by adrenaline and the inhibition by insulin of glycogenolysis and lipolysis in adipose tissue have been interpreted in terms of effects of cyclic AMP (adenosine 3': 5'-ycyic monophosphate) (on protein kinase) leading to activation of glycogen phosphorylase and triglyceride lipase (Jungas, 1966; Robison, Butcher & Sutherland, 1968; Huttunen, Steinberg & Mayer, 1970) . Adrenaline has been shown to elevate adipose tissue concentrations of cyclic AMP and insulin to lower them. The effects of adrenaline on lipolysis and tissue cyclic AMP concentrations are reproduced by adrenocortiocotrophic hormnone and dibutyryl cyclic AMP (6-N,2'-O-dibutyryl adenosine 3': 5'-cyclic monophosphate) whereas the effects of insulin on these parameters are reproduced by prostaglandin El (Robison et al. 1968; Butcher & Baird, 1968) .
Because of the possibility that insulin and adrenaline might influence the activity of pyruvate dehydrogenase through their effects on adipose tissue cyclic AMP concentration, studies have also been made of the effects of these other agents. In the light of these results and other published work we discuss the possible mechanism of these hormonal effects and interactions, and in particular the extent to which known variations in the tissue concentration of cyclic AMP provide an adequate explanation for these phenomena.
While this work was in progress Jungas (1970, 1971) reported evidence for activation of adipose tissue pyruvate dehydrogenase by insilin and inhibition by adrenaline and for control of enzyme activity by a phosphorylation-dephosphorylation cycle. Some of the present results have been published in preliminary form (Denton, Coore, Martin & Randle, 1971a; Coore, Denton, Martin & Randle, 1971; Denton, Martin, Coore & Randle, 1971b Simon & Shemin (1953) ; arylamine acetyltransferase (EC 2.3.1.5) was prepared from pigeon livers by the method of Tabor, Mehler & Stedtman (1953) .
Anti-insulin sera prepared by the method of Robinson & Wright (1961) Isolated fat-cell8 and fat-cell mitochondria. These were prepared as described by Enzyme a8say8. All assays were conducted at 300C. Control experiments showed in each case that rates of reaction were proportional to the volume of extract used, the concentrations of substrates used gave maximum reaction rates and that the rates were constant over the period of assay (2-5min). Blanks were included in each case by omission of one substrate.
Pyruvate dehydrogenase was assayed spectrophotometrically by coupling with arylamine acetyltransferase (Tabor et al. 1953) , and following the change in extinction at 460nm due to acetylation of p-(p-aminophenylazo)-benzenesulphonic acid (Jacobson, 1961) . The assay was conducted in 100 mM-tris chloride buffer, pH 7.8, containing EDTA (0.5mM), MgCl2 (1 mm), mercaptoethanol (5mM), thiamine pyrophosphate (1 mm), NAD (0.5mm), CoA (0.1 mM), pyruvate ( mm), p-(p-aminophenylazo)-benzenesulphonic acid (10,g/ml) and arylamine acetyltransferase (0.1 unit/ml). Glutamate dehydrogenase (EC 1.4.1.2), ATP citrate lyase (EC 4.1.3.8) , NADmalate dehydrogenase (EC 1.1.1.37), NADP-malate dehydrogenase (EC 1.1.1.40) and pyruvate carboxylase (EC 6.4,1.1) were assayed as described by Martin d& Denton (1970) . Citrate synthase (EC 4.1,3.7) was assayed by a slight mollification of the method of Srere, Barzil & Conen (1963) . Final concentrations in the cuvette were acetyl-CoA 50,UM, oxaloacetate O.1mM and 5,5'-dithiobis-(2-dinitrobenzoic acid ) 0.1 mm in tris chloride buffer, pH 7.4 (0.1 m). Acetyl-CoA carboxylase (EC 6.4.1.2) was assayed by a modification of the methods of Martin & Vagelos (1962) and Saggerson & Greenbaum (1970b) . Fat-pad extract (2001I) was added to 50mM-triethanolamine buffer, pH 7.4, containing 80 mM-potassium citrate, 20mM-MgCl2, 8mm-MnCl2, 30mM-KH14CO3 (l0,uCi/,umol), 10mm-ATP, 1 mM-dithiothreitol and 0.15mM-acetyl-CoA in a total volume of 1.2ml. After 10min at 300C, the reaction was terminated by addition of 200p.l of 5M-HCl and 14C02 was removed in vacuo after addition of 501A of saturated KHCO3. A sample (200,4u) was then transferred to a scintillation bottle, heated to dryness at 850C (about 30min) and assayed for radioactivity after addition of 200pul of water and lOml of methoxyethanol-toluene-based scintillator. Controls lacking acetyl-CoA were carried through the procedure.
Analysis of incubation media. Glucose, lactate and glycerol were measured spectrophotometrically in neutralized HC104 extracts of incubation media and uptakes and outputs were calculated as described by Denton & Randle (1967) . For assay of pyruvate, media were acidified with HC104 immediately after incubation and assays performed without neutralization within 2h by the method of Bucher, Czok, Lamprecht & Latzko (1963) . Fructose was assayed by the method of Klotzsch & Bergmeyer (1963) . Citrate and malate outputs of fat-cell mitochondria were measured as described by .
RESULTS AND DISCUSSION
Effects of insuin on gluco8e and fructose metabolism in vitro. Fig 1(a) shows that insulin stimulates the rate of glucose uptake by incubated epididymal fat-pad by more than tenfold whereas the rate of fructose uptake was little changed by the hormone in this particular experiment. By pooling results from several experiments, it was, however, possible to show that insulin accelerates fructose uptake by 42±7.7% of the control rate in paired fat-pads (P<0.02; data of Table 1 ). The effect of insulin on the incorporation of 14C from [U_14C]fructose into glyceride fatty acids appeared to be somewhat larger (Table 1) . Table 2 shows that the rate of this mitochondrial conversion of pyruvate into citrate and malate is increased when fat-cells are exposed to insulin before isolation of the mitochondria. Apparently an insulinsensitive step in the mitochondrial metabolism of pyruvate had retained increased activity in spite of the drastic environmental alterations involved in the isolation and incubation of mitochondria. As shown in Table 2 mitochondria prepared from fatcells exposed to insulin also showed increased rates of citrate formation on incubation with pyruvate and malate in the presence of uncoupler m-chlorocarbonylcyanide phenylhydrazone. Under these conditions (low ATP and bicarbonate, presence of malate) pyruvate carboxylase is non-functional and the oxaloacetate utilized in citrate formation was Table. 1. Effect of insulin on the metabolism offructose by epididymalfat-pad.
Fat-pads, paired in groups of two to six pads, were preincubated for 30 min in medium containing fructose (2mg/ml) and then incubated for a further 30min in fresh medium containing [U-_4C]fructose (2mg/ml and 0.1 uCi/ml); one flask of each pair contained lOmU of insulin/ml. Results are given as mean values ±5.E.m. (Table 4 ). The activity of the exclusively mitochondrial enzyme, glutamate dehydrogenase , was measured as a convenient index of recovery of mitochondrial enzymes. Its activity was unaffected by inssulin treatment (Tables 3 and 4 ) and in subsequent experiments the pyruvate dehydrogenase/glutamate dehydrogenase activity ratio has been used as an index of changes in the activity of pyruvate dehydrogenase. Table 3 shows in addition that the effect of insulin on pyruvate dehydrogenase activity was not dependent on the presence of a substrate such as glucose or fructose in the incubation medium. We conclude from this that the effect of insulin on pyruvate dehydrogenase is not dependent on its effect on the membrane transport of glucose (or fructose). It is notable that in the non-insulintreated tissue pyruvate dehydrogenase has the lowest maximum activity of all those enzymes concerned with the incorporation of pyruvate carbon atoms into fatty acid whose activity was measured, which is also suggestive that it might be a control point in the process. Further, the enzyme activity after exposure to insulin is in 'the range 10-20,umol/h per g of wet tissue at 370C (assuming enzyme activities double for each 100C rise in temperature). This would be sufficient to account for published rates of carbon atom flow through pyruvate dehydrogenase when fatty acids are synthesized from glucose with insulin (Saggerson & Greenbaum, 1970a; Flatt & Ball, 1964; Katz & Rognstad, 1966) . It is also noteworthy that the observed increase in pyruvate dehydrogenase activity due to insulin is comparable with the magnitude of the hormonal effect on fatty acid synthesis from fructose (Table 1) . Most experiments involved a 30min exposure to insulin but it was possible to detect a significant effect of the horinone on fat-pad pyruvate dehydrogenase after only lOmin exposure to the hormone in vitro (activity When administered in vivo an even greater effect of insulin on fat-pad pyruvate dehydrogenase could be demonstrated. Pentabarbitone-anaesthetized rats (approx. 60mg/kg by intraperitoneal injection) were injected via tail veins with either 250,u1 of guinea-pig anti-serum or 0.3 unit of bovine insulin in 250,d of non-immune guinea-pig serum. After 15min the epididymal fat-pads were quickly removed, frozen and ground under liquid N2. Extraction and assay of pyruvate dehydrogenase and glutamate dehydrogenase were then carried out as detailed in the Experimental section. Blood glucose determinations at time of removal of tissue showed animals treated with anti-insulin serum to have concentrations of 150mg/100ml or above and insulin-treated animals to have concentrations of below 90mg/I00ml. Activity of pyruvate dehydrogenase in extracts of fat-pads from rats treated with anti-insulin serum was 0.053 ±0.015/imol/min per g of wet tissue and this was increased in pads from insulin-treated rats to 0.237±0.045btmol/min per g of wet tissue (means ±s.E.M. for four observations in each case). There was no detectable difference in the activity of glutamate dehydrogenase.
Effects ofadrenaline, adrenocorticotrophic hormone, dibutyryl cyclic AMP and prostaglandin E1 on pyruvate dehydrogenase. Exposure of fat-pads to adrenaline (1 jug/ml) for 30min almost completely abolished the stimulatory effect of insulin on pyruvate dehydrogenase but adrenaline failed to diminish the-activity of the enzyme in the absence of insulin (Table 5) . However, in a separate experiment in which adrenaline exposure was limited to lOmin, pyruvate dehydrogenase activity was decreased to 78 ± 1.5% of the control value (mean± S.E.M. for four observations; P<0.01). In a further experiment with fat-cells prepared with collagenase, adrenaline after 30min incubation markedly decreased the activity of the enzyme and this inhibition was prevented by the ,-blocker propanolol at 10,g/ml (Table 5) . Adrenocorticotrophic hormone and dibutyryl cyclic AMP were also found to reverse the stimulatory effect of insulin on pyruvate dehydrogenase (Tables 6 and 7) . Prostaglandin E1 had no significant effect on pyruvate dehydrogenase although decreasing the rate of lipolysis to an extent similar to that ofinsulin (Table 6 ). In a further experiment, prostaglandin El again failed to increase pyruvate dehydrogenase activity but clearly diminished the rate of glycerol output. Combining the results of the two experiments, the activities of pyruvate dehydrogenase after exposure to insulin and prostaglandin El Iwere respectively 153±12% and 98±9% of the control value whereas the rates of glycerol output were respectively 604+6% and 47±5% of control kidney, heart and brain have been shown to exist in phosphorylated (inactive) and non-phosphorylated (active) forms (Linn et al. 1969; Wieland & Siess, 1970; Siess et al. 1971) . The interconversions were found to be mediated by an ATP-dependent kinase and a Mg2+-stimulated phosphatase. Evidence for the operation of a similar system in adipose tissue has been obtained as follows.
Addition of ATP to uncoupled fat-cell mitochondria incubated in the presence of pyruvate and malate led to a marked decrease in citrate output and to a parallel diminution in the activity of pyruvate dehydrogenase subsequently extracted from the mitochondria ( Table 8) .
Addition of MgATP2-(1mm) or MgCl2 (1OmM) to extracts of whole fat-pads incubated at 200C led to some inhibition and activation respectively of pyruvate dehydrogenase activity but the effects were small and variable. However, clear and consistent evidence for inhibition of fat-cell pyruvate dehydrogenase by ATP and activation by Mg2+ was obtained from observations of the effects of additions of ATP and Mg2+ to extracts of fat-cell mitochondria. In the experiment shown in Fig. 2 , mitochondria were isolated from non-insulintreated fat-cells and extracted by freezing and thawing in 30nmM-potassium phosphate buffer, pH 7.0, containing 0.5mM-MgCl2, oigomycin (1,ugfml) and 5mM-mercaptoethanol. Pyruvate dehydrogenase activity in this extract was constant during incubation at 300C for at least 30min. If, however, MgCl2 (10mM) was added the activity was markedly increased until, after 20-30min, the pyruvate dehydrogenase/glutamate dehydrogenase ratio was about 0.6; on tenfold dilution with magnesium-free phosphate buffer activity declined only very slowly but after addition of ATP (0.1 mm) activity was rapidly lost and after 30min the pyruvate dehydrogenase/glutamate dehydrogenase ratio was less than 0.05. When the order of addition ofATP and Mg2+ was reversed it was found that the loss of activity seen with ATP was overcome on the subsequent addition of MgC12 (10mM).
As shown in Table 9 , the difference in pyruvate dehydrogenase activity between extracts of mitochondria prepared from insulin-treated and those from non-insulin-treated fat-cells could be eliminated by incubation with lmM-MgATP2-or with IOmM-Mg2+. This finding suggests that the activating effect of insulin on pyruvate dehydrogenase is the result of an increase in the proportion of the active (dephosphorylated) form of the enzyme. Some further support for this conclusion is provided by the observation (Fig. 3) that insulin treatment of fat-cells increased the Vmax. of pyruvate dehydrogenase in extracts of mitochondria prepared from them without altering the Km for pyruvate. (The results in Fig. 3 give Km±s.E.M. Table 6 . Effects of insulin, prostaglandin E1 and adrenocorticotrophic hormone on pyruvate dehydrogenase and glycerol output of epididymalfat-pads Procedure was as given in the legend to Table 8 . Effect of A TP on citrate production by and activity of pyruvate dehydrogenase in uncoupled fat-cell mitochondria incubated with pyruvate and malate Mitochondria were prepared from non-insulin-treated fat-cells and preincubated at 30°C for 9min in 130mm-KCl, 2mM-MgCl2, 2mM-ethanedioxybis(ethylamine)tetra-acetate, 0.5,ug of m-chlorocarbonyl cyanide phenylhydrazone/ml and 1 ,ug of oligomycin/ml with or without addition of ATP (5 mM). Pyruvate (5mM) and malate (5mm) were then added and the mitochondria incubated for a further 5 min. Some samples of mitochondria and their incubation media were used for determination of citrate production and other samples for the determination of enzyme activities. (2) was always included in the incubation medium in experiments with adrenaline with the object of preserving tissue concentrations of ATP. Adrenaline (but not insulin) can lower fat-pad concentrations of ATP on incubation without substrate (Hepp, Challoner & Williams, 1968; Bihler & Jeanrenaud, 1970) Mitochondria were prepared from insulin-treated or non-insulin-treated cells as described in the legend to Table 2 and extracted by freezing and thawing in 30mM-potassium phosphate buffer containing oigomycin (0.5pg/ml) and mercaptoethanol (5mM). Activities of pyruvate dehydrogenase and glutamate dehydro. secondaxy rise in pyruvate dehydrogenase seen with adrenaline under such conditions (Jungas, 1971) . Effects of cyclic AMP on pyruvate dehydrogenase. These experiments were of two types. In one type cyclic AMP was added to the incubation medium of intact mitochondria and the activity of extracted pyruvate dehydrogenase measured; in the other cyclic AMP was incubated with the enzyme extracted either from whole fat-pads or isolated fat-cell mitochondria and the subsequent timecourse of enzyme activity was then followed.
In a series of experiments of the first type mitochondria were prepared from insulin-treated fatcells and incubated in potassium chloride (130mM), potassium dihydrogen phosphate (2mM), pyruvate (1.5mM), potassium bicarbonate (12.5mM), pH7, and either ethanedioxybis(ethylamine)tetra-acetate (2 mM) or ethanedioxybis(ethylamine)tetra-acetate- Ca2+ buffer such that free Ca2+ concentration was 1 or 0.1 ,LM. Addition of cyclic AMP (250 pAM) during 15min incubation at 30°C did not influence activity of extracted pyruvate dehydrogenase.
Because of the possibility that an effect of cyclic AMP might require an extramitochondrial factor another experiment was performed as follows. Insulin-treated fat-cells were broken in sucrose (200mm), magnesium chloride (1.5mM), potassium bicarbonate (20mM), GSH (10mM), tris chloride (20mm), pH7.3, ethanedioxybis(ethylamine)tetraacetate-Ca2* (2mm) (free Ca2+1 ,UM) and 2% defatted bovine serum albumin with and without 0.5mM-ATP, with and without 250,uM-cyclic AMP. After centrifugation the infranatant was removed from the fat plug, gassed with 02+C02 (95:5) and incubated at 300C with shaking for lOmin. The mitochondria were spun down and extracted as usual. A definite inhibition of pyruvate dehydrogenase activity was observed in the presence of ATP but this was not increased by the presence of cyclic AMP at 250pM.
The experiment described above involved great but unavoidable dilution of the extramitochondrial components of the fat-cell. It could be argued that cyclic AMP required a higher concentration of cytoplasmic protein kinase to exhibit effects on intramitochondrial enzyme activities though the mechanism of such an effect would be obscure.
Mitochondria were therefore prepared from insulintreated fat-cells and incubated in potassium chloride (130mM), magnesium chloride (2mM), tris chloride (20mM) and oligomycin (0.5,ug/ml) with and without ATP (1mM). ATP-containing media were in some cases supplemented with 0.15mg of protein/ml of crude protein kinase from skeletal muscle (prepared as described by Walsh, Perkins & Krebs, 1968, up to the stage of DEAE-cellulose chromatography) and/or cyclic AMP (0.1 mM). Extracted pyruvate dehydrogenase activity was unaffected by previous exposure of mitochondria to protein kinase and cyclic AMP alone or combined.
In several experiments extracts of pyruvate dehydrogenase from frozen fat-pads or from isolated mitochondria from non-insulin-treated and insulintreated fat-cells were incubated in 30mM-phosphate buffer, pH 7, containing oligomycin (0.5 ,g/ml), magnesium chloride (0.5mm) and mercaptoethanol (5mM) for up to 45min at 300C with and without MgATP2-(1 or 0.5mM). Inhibition of enzyme activity by ATP was always shown but this was not increased by the further addition of cyclic AMP (0.1mm). Cyclic AMP by itself was also without effect. However, in an experiment in which skeletal-muscle protein kinase (0.15mg of protein/ ml) was also present along with cyclic AMP during 15min incubation, enzyme activity was decreased to 28 ± 3% of control (control: lacking ATP, protein kinase and cyclic AMP) whereas ATP alone only decreased activity to 51+4% of control (mean is.E.M. for four observations in each case).
From this we conclude that cyclic AMP was unable to activate the intrinsic kinase of pyruvate dehydrogenase under conditions in which it could activate muscle protein kinase. Evidently pyruvate dehydrogenase is susceptible to inhibition, presumably owing to phosphorylation, by extrinsic activated protein kinase, but only when the two enzymes are in free solution not separated by the mitochondrial membrane barrier.
General discussion. These effects of insulin and adrenaline on pyruvate dehydrogenase have clarified some of the earlier observations on the physiological control of fatty acid synthesis in rat epididymal adipose tissue but we wish to emphasize that there is evidence which suggests a further point of control beyond the stage of citrate formation. It is well established that the whole cell concentration of citrate in adipose tissue is unchanged when carbon atom flow from glucose through citrate to fatty acid is maximally stimulated by insulin. Moreover, addition of adrenaline can then greatly increase citrate concentration and decrease the rate of flow of glucose carbon atoms to fatty acid Saggerson & Greenbaum, 1970a,b). 125 Vol. 125 H. G. COORE, R. M. DENTON, B. R. MARTIN AND P. J. RANDLE One possibility is that insulin and adrenaline could, by altering the citrate concentration gradient across the mitochondrial membrane, regulate the cytoplasmic citrate concentration and thereby alter the rate of flow through ATP citrate lyase. Another possibility is that insulin and adrenaline could act on a further enzyme in the pathway in the span between citrate and fatty acid.
Our experiments raise the question of the mechanism of action of insulin on pyruvate dehydrogenase but only allow us to suggest plausible alternatives in the light of the vast literature on insulin action. We shall assume for the purposes of discussion that the effect of insulin is to increase the proportion of dephospho-pyruvate dehydrogenase by either inhibition of the kinase or activation of the phosphatase or both. We shall confine our attention almost entirely to the fat-cell and assume not only that insulin acts on the cell but also that it does not enter and act within adipose cells. There appears to be no fully satisfactory demonstration ofthis though experiments with Sepharose-bound insulin (Cuatrecasas, 1969) have been interpreted in this way. This view implies that the effects of insulin on glycogen synthetase and phosphorylase (Jungas, 1970) , on triglyceride lipase (Loffler & Weiss, 1970) and now on pyruvate dehydrogenase are not mediated by direct interaction of insulin with the enzyme systems concerned. In fact, we have not found any effect on pyruvate dehydrogenase of insulin added directly to a mitochondrial suspension but we realise that such an experiment is not conclusive. It would also seem unlikely that insulin added to intact cells is able to penetrate both the plasma membrane and the inner mitochondrial membrane within which pyruvate dehydrogenase is situated.
If then we assume that insulin acts only at the plasma membrane the question arises of how an effect at that site influences the activity of pyruvate dehydrogenase within the mitochondria. Although other possible links could be imagined, some form of 'second messenger' hypothesis seems most likely as a natural extension of Sutherland's concept for the action of adrenaline, glucagon, adrenocorticotrophic hormones and other hormones. Specifically, in view of the reported ability of insulin to lower cyclic AMP in fat-cells (Butcher, Sneyd, Park & Sutherland, 1966) it has been pertinent to consider whether cyclic AMP could mediate the effects of insulin and its hormonal antagonists on pyruvate dehydrogenase.
We have not directly measured fat-cell cyclic AMP in the conditions of our experiments but with fructose as a substrate insulin showed a consistent anti-lipolytic effect, as shown by glycerol release from incubated fat-pads. Butcher (1970) has summarized the evidence correlating the effects on adipose tissue lipolysis with tissue concentrations of cyclic AMP and the extracted triglyceride lipase has been shown to be activated by cyclic AMP (Rizack, 1964; Huttenen et al. 1970) .
Our results indicate that adrenaline and adrenocorticotrophic hormone both stimulated lipolysis and hence presumably elevated cyclic AMP while antagonizing the stimulation of pyruvate dehydrogenase by insulin. The precise mode of action of dibutyryl cyclic AMP is not known but it is generally accepted as providing a means of reproducing the effects of cyclic AMP in intact cell preparations (Butcher, 1970) and in our experiments its effects were similar to that of adrenocortotrophic hormone and adrenaline.
These results are consistent with the idea of cyclic AMP as a 'second messenger' capable of inhibiting pyruvate dehydrogenase. On this hypothesis insulin would act by lowering tissue cyclic AMP, thus releasing the inhibition. The experiments with prostaglandin El, however, cannot be reconciled with this hypothesis. Prostaglandin El diminished lipolysis to an even greater degree than insulin and hence presumably lowered cyclic AMP to at least the same extent, yet it failed to stimulate pyruvate dehydrogenase. Since prostaglandin El did not impede the action of insulin the possibility of some other unrelated action of prostaglandin E1 on pyruvate dehydrogenase seems remote. Further, we have failed to detect any effects of cyclic AMP on the activity of pyruvate dehydrogenase in intact mitochondria or in mitochondrial extracts incubated under a variety of different conditions. Perhaps the simplest interpretation of these findings is to consider the possibility that insulin action at the fat-cell membrane leads directly or indirectly to the production of a further second messenger which activates pyruvate dehydrogenase, and which is in some way antagonized by cyclic AMP. This antagonism might be the result of an interaction at the level of pyruvate dehydrogenase regulation and/or at sites of formation or destruction of cyclic AMP and this hypothetical second messenger. It may be noted in this connexion that Loten & Sneyd (1970) found that insulin treatment of fat-pads may increase the activity of cyclic AMP phosphodiesterase measured in extracts of the tissue. It is perhaps unlikely that this could result from a fall in the tissue concentration of its substrate (cyclic AMP).
